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Cat scratch disease (CSD) is a world-wide, diffuse, non-epidemic infection caused by the Gram-negative bacillus Bartonella
henselae. The occurrence of encephalopathy represents an infrequent and atypical complication, whose manifestations include
ischemic strokes, transverse myelitis and epileptic seizures. Status epilepticus has been described as the most frequent emergency
in CSD encephalopathy. In this report, we describe a case of CSD complicated by an epilepsia partialis continua (EPC) manifested
as rhythmic movements of the flexor muscles of the left hand. Although CSD is a benign, self-limited disease and a complete
neurological recovery usually occurs, in the present case the EPC resulted in a partial epilepsy. Magnetic resonance imaging
(MRI), single photon emission computed tomography (SPECT) and back-averaged EEG data recorded during myoclonic activity
document this CSD complication.
© 2003 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.
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INTRODUCTION
Cat scratch disease (CSD) is a relatively common
cause of local, benign and self-limited lymph node
alteration1, seldom associated with involvement of
the central nervous system (CNS)2. Bartonella hense-
lae, a Gram-negative bacillus, is the aetiologic agent
of the disease3, 4. Usually benign, it may induce
encephalopathy and seizures, either manifested as
isolated attacks or status epilepticus5–7.
Although CSD-induced encephalopathy is an in-
frequent manifestation and several hypotheses have
been suggested as possible pathogenetic factors of the
neural damage, the aetiopathogenesis of this compli-
cation remains unclear.
In this study, we describe a case of CSD en-
cephalopathy characterised by an unusual manifes-
tation of epilepsia partialis continua (EPC), followed
by residual partial epilepsy.
SUBJECT AND METHODS
Six weeks after being scratched on the hands by a
pet kitten, a 17-year-old female living in suburban
South Sardinia (Italy), developed an acute, progres-
sive frontal headache, followed by several episodes of
tonic convulsions and a state of disorientation and con-
fusion lasting 2 hours. An examination of her previous
medical records provided no remarkable findings.
Neurological examination and blood samples, per-
formed soon after the patient’s admission to hospi-
tal, yielded a sedimentation rate of 35 mm/hour, a
WBC count of 17 000 with a left shift, and a body
temperature of 38 ◦C. A lumbar puncture yielded
clear, cell-free cerebral spinal fluid (CSF) with a nor-
mal protein content, negative for oligoclonal bands.
The search for a possible autoimmune genesis with
the study of anti-nuclear antibodies, anticardiolip-
ine, anti-neutrophil cytoplasmic antibodies (ANCAs)
tested for c-ANCAs and P-ANCAs, IgG and IgM,
ENA screening, and the test for lupus-like anticoag-
ulant (DRVVT and DRVVT miscela ratio) yielded
normal results. Moreover, since CSD may complicate
acquired immunodeficiency diseases, the subject was
tested for the antibodies HIV 1, 2 (ELISA: not reac-
tive) and for CD4/CD8 (ratio 1.08). In order to rule out
other possible causes of encephalitis, the TORCH test
was also performed (ELISA: antibodies absent). An
EEG recorded 2 hours after admission showed diffuse
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Fig. 1: T2-weighted brain MRI reveals two large, well-defined areas of an increased bright signal without mass effect within
the right frontal cortex.
slow activity that was larger in the frontal–parietal
right leads. A brain magnetic resonance imaging
(MRI) performed at the same time showed cortical
and subcortical lesions on the right hemisphere that
failed to show contrast enhancement after gadolinium
(Fig. 1). Antiepileptic treatment with Carbamazepine
(CBZ) was started at the dose of 600 mg/day. After
the first episodes of seizures, the patient showed six
episodes of myoclonic movements during the follow-
ing 48 hours, which were localised to the flexor digi-
torum of the left hand and lasted from 4 to 15 seconds
and occurred without alteration of the status of con-
sciousness. Four days after admission, the patient
manifested an episode of EPC characterised by rhyth-
mic myoclonic movements of the flexor digitorum of
the left hand (2–4 cycles/second). This episode was
reported to the medical staff by the patient 15 minutes
after its onset. The patient’s status of consciousness
was apparently normal, but when she was asked about
her feelings after the episode, she described a ‘sensa-
tion of extraneity without fear’ as if the episode ‘oc-
curred to another person’. This manifestation lasted
37 minutes. Under polygraphic video-EEG record-
ing (Brain Quick System 98, Micromed, Mogliano
Veneto, Italy), the patient was treated with an i.v.
bolus of 10 mg Clonazepam, which was followed by
a complete remission of the clonic movements and a
suppression of the spiking activity with persistence of
the slow waves. The polygraphic EEG tracings were
subsequently back-averaged off-line.
The EMG obtained from the left flexor digitorum
was evaluated with respect to the EEG activity of
the corresponding sensory-motor area recorded at the
right temporal–parietal leads. This analysis showed
a concordance between the movements of the sec-
ond and third finger of the left arm and the spikes
recorded at the right temporal–parietal leads (Fig. 2).
Moreover, visual, acoustic and sensory evoked poten-
tials (VEPs, BAEPs and SSEPs), yielded normal re-
sults. A single photon emission computed tomography
(SPECT) performed during the interictal phase after
the first seizure episode with 740 MBq of 99mTc-ethyl
cysteine dimer (ECD) showed several areas of cortical
and subcortical hypoperfusion localised in the right
cortex (Fig. 3). Five days after admission the patient
manifested a cutaneous rash and an axillary and cervi-
cal lymphadenopathy. As the patient was treated with
CBZ, this manifestation was considered a side effect
of this treatment. The CBZ was discontinued and the
treatment was shifted to 600 mg/day of valproic acid
(VA).
Since the patient’s temperature persisted at 38.5 ◦C,
the anamnestic observation of a cat scratch associated
with transitory lymphadenopathy, attributed ‘prima
facie’ to CBZ treatment, suggested the rationale of a
test for CSD. Indirect fluorescent antibody testing for
CSD revealed B. henselae serology positive at a titre
of 1:186 (cut-off: 1:58) 10 days after the onset of
the symptoms. This positivity prompted a CSF PCR
analysis in the attempt to establish B. henselae as the
specific cause of the seizure disorder, but the results
were negative. Tests for mononucleosis, Group A
Streptococcus, syphilis, tuberculosis and brucellosis,
were negative. Tests for ‘Tularaemia’ were not per-
formed as this disease has never been described in
Sardinia and, although not infrequent in Central Eu-
rope, it is rare in all South Mediterranean countries.
Though there is no general agreement on the efficacy
of the antibiotic treatment in CSD, the unusual sever-
ity of the symptomatology urged us to treat the subject
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Fig. 2: EEG and back-averaging. Left: Desynchronised activity mixed with diffused theta waves. The EMG shows bursts of
myoclonic activity in the muscle proper flexor of the third finger. Right: Back-averaging of 300 events shows the coherence
between myoclonus and right frontal–parietal spikes.
with Amoxicilline at a dose of 3 g/day. This therapy,
which was maintained for 1 week, was followed by
a dose of 1.5 g/day for 2 weeks. Though complete
regression of the temperature was observed within 4
Fig. 3: 99mTc-ECD cerebral SPECT shows frontal, parietal
and temporal cortical right hypoperfusion.
days after antibiotic administration, myoclonic move-
ments were sporadically observed. In particular, this
abnormal motor pattern, strictly localised to the sec-
ond and third finger of the left hand, lasted 1–3 to
5–8 seconds, and was reported by the patient and her
family members, who witnessed attacks with one to
four episodes a day. Despite the fact that VA was in-
creased to 1200 mg/day for the optimal serum range
of 83µg/ml, isolated myoclonic jerks were observed
for 5 weeks. The serum titre for Bartonella, which
was repeated after 2 months, returned to 1:86.
MRI controls were scheduled weekly during 2
months. Three weeks after the first examination, MRI
showed an almost complete regression of the cortical
and subcortical lesions, while new small alterations
similar to those described initially were observed (not
shown). This finding and the occasional myoclonic
movements of the second and third finger of the left
hand contrasted with the normal neurological and
psychological conditions of the subject. Clinical nor-
malisation was assessed with a further MRI at the
end of the second month, which yielded a completely
normalised finding. The patient was discharged 10
weeks after admission and the antiepileptic treatment
was monitored. A new MRI and a SPECT performed
after 2 more months confirmed the absence of cere-
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Fig. 4: EEG after 24 months of 8–12 Hz low-voltage irregular activity mixed with rare spikes localised over the right
frontal–parietal leads.
bral alterations. The patient was monitored with EEG
recordings every 2 months. Despite the clinical re-
mission, the EEG showed rare low-voltage spiking
activity localised in the right parietal–temporal leads.
Fourteen months after the first episode, the patient
experienced a feeling of ‘sudden confusion’ lasting
about 1 minute. A new EEG showed medium-voltage
temporal–parietal spiking activity (Fig. 4) and con-
sequently the diagnosis of secondary partial epilepsy
was considered. VA was reduced (300 mg/day)
and lamotrigine (LMT) was added at the dose of
50 mg/day. After a slow increase (steps of 50 mg every
10 days), the optimal dose of LMT for seizure control
was established at 300 mg/day and VA was discon-
tinued. Though LMT proved efficient in preventing
further seizures, the EEG follow-up, including the
last record 2 years after the episode, documented a
right frontal–temporal–parietal focus represented by
isolated medium-voltage spikes.
DISCUSSION
This partialis status epilepticus, more appropriately
defined in this report a case of EPC, represents a
rare complication of CSD. Our patient fulfils three
out of the four criteria established for the diagnosis
of CSD8, namely, history of exposure to cats, pres-
ence of scratches, and positive B. henselae specific
test. The fourth criterion, i.e. the finding of lymphatic
involvement, can only be suspected, as the transitory
lymph node swelling and cutaneous rash had been in-
terpreted as a side effect of CBZ treatment rather than
a CSD manifestation. Accordingly, no further steps
had been taken towards a histological examination of
the lymph nodes, and the possible relevance of this
finding, which only gives significant results up to a
few days9, was no longer considered.
The mechanism by which B. henselae mani-
fests its neurotropism remains elusive, though an
immune-mediated vasculitis has been suggested10 as
a causative agent, mainly because the irregular struc-
ture of the cerebral vessels, which showed findings
similar to that of cerebral autoimmune arteritis, has
been described in some patients after ischemic strokes
secondary to CSD11.
The extension and the aspect of MRI findings are not
specific though similar to those described in a recent
CSD case report12. However, though the occurrence of
a transient, rapidly changing MRI hyperintensity may
reflect modifications occurring in vasculitic tissues,
we cannot rule out that this finding may represent the
outcome of localised vascular inflammation rather
than the inflammation itself13. The involvement of
the right sensory-motor area in the process may play
a role in the ‘sensation of extraneity’ experienced by
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our patient during the EPC which may be regarded as
part of the seizure episode. Although in the present
case a specific immune-mediated aetiology should
be considered unlikely since common autoantibodies
were negative, nonetheless an autoimmune patho-
genesis cannot be completely ruled out. It has been
suggested that circulating antibodies can induce an im-
mune response by focal disruption of the blood–brain
barrier (BBB) and may interact with synaptic recep-
tors structurally similar to bacteria periplasmic amino
acid-binding proteins14. This penetration mechanism
may give access to the neural structure to circulating
pathogenic antibodies, promoting an interaction with
brain antigens. One possible consequence of the subse-
quent neural injury could be the induction of seizures.
Several experimental15 and clinical16 data show that
focal seizures induce a further local transient increase
in the permeability of BBB, activating a cascade of
pathologic events eventually leading to the permanent
activation of an epileptic focus. Since encephalitis
represents a rare and occasional complication of CSD,
it seems likely to hypothesise that in some subjects the
disease may induce an unusual autoimmune response.
It could be speculated that this mechanism may be
raised against specific receptor domains in a similar
way as that described within synapses in the patho-
genesis of other epileptogenic encephalitis17 and,
depending on the individual reactivity, it could have
a role in the activation of the epileptogenic process.
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